Was Mylan The First To Set Its Sights On Ranbaxy?
This article was originally published in PharmAsia News
Executive Summary
Way before Sun Pharma swooped in to buy Ranbaxy, industry experts say Mylan may have taken a close look at buying the company. Although the world’s fourth-largest drug maker pulled out initially, sources say negotiations may still be revolving around sourcing raw materials for esomeprazole, an exclusive drug launch opportunity that could brighten Ranbaxy’s U.S. fortunes.